Cadus Pharmaceutical Corp. (KDUS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)

KDUS 1.600

0.0%

Jul 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (207)	8/15/2000 5:11:14 AM
From: dalroi	Read Replies (2) of 1833

well, i'm going over it unless i missed it i couldnt find the percentage however found this Equity In Other Ventures For the three months ended June 30, 2000 the Company recognized a net loss of $353,884 in its investment in Axiom Biotechnologies, Inc. and Laurel Partners Limited Partnership. The loss for the same period in 1999 was $359,144. which let see a drop off 5000$ now biacore paid 4m for a ? stake in axiom and reported it may 22 so lets see drop off 5K represents rough 1.5% as its reported may 22 or after half the q lets assume that for the entire q it would be 3% Found this in an earlier 10 K Following the JAFCO investment, the Company began recognizing 50% of the net losses generated by Axiom which is the extent to which the Company is deemed to be funding such losses so 50% they own 3% less or we could say that 6% off the compagny equals 4M$ or 4*100/6= +- 66m so this would make kdus stake worth around 30m or 2.5$/ share i realise there are a lot off ifs in it most important it requires a stable "loss" in the venture cheers Stefaan Comments appreciated

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next